The FDA has approved the first cervical cancer testing kit that allows women to collect their own sample at home before ...

President Trump is expected to advance a "most-favored nation" policy to lower drug prices. How effective might it be? The devil will be in the details.

A proposal to require four years of emergency residency “threatens to burden future residents while failing to meaningfully ...

House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

As Trump attacks on Harvard gain momentum, researchers are scrambling: "Everyone can read the writing on the wall." ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at ...

DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35% ...

Researchers calculated that $1.8 billion in National Institutes of Health grants were terminated in just over one month ...

UnitedHealth Group seemed immune from the higher costs and systemic changes in the Medicare Advantage program that bedeviled ...